KZIA Kazia Therapeutics Limited - American Depositary Shares
NASDAQ · Biotechnology · Lihat di SEC EDGAR ↗ tutup Okt 2, 2026 10-K/10-Q Nov 7, 2025
$9,27
· % dari rentang 52 mgg
· di atas terendah
· ke tinggi
$4,91rendah 52m
$17,40tinggi 52m
P/E
-165.9
EPS
$-0.04
Pendapatan
$42.0K
lencana Anda
Rentang 52M
$5–$17
Peringkat Analis
BUY
Target Harga
$28
P/E
-165.9
ROE
226.0%
Margin Laba Bersih
-49290.5%
Strip lencana Anda kosong — sematkan metrik di mana saja di halaman ini.
KZIA Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$9.27
P/E
-165.9
EPS
$-0.04
Pendapatan
$42.0K
ROE
226.0%
Rentang 52M
$5–$17
KZIA Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
rentang
batang
Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.
Pemecahan saham
| Tanggal ex-dividen | Pemecahan | Tipe |
|---|---|---|
| 17 April 2025 | 1-for-5 | Terbalik |
| 28 Okt. 2024 | 1-for-10 | Terbalik |
| 14 Juli 2017 | 1-for-4 | Terbalik |
| 28 Jan. 2013 | 1519-for-500 | Maju |
| 3 Jan. 2012 | 1-for-5 | Terbalik |
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Pendapatan$42.0K2017-06-30 → 2025-06-30
EPS$-0.042017-06-30 → 2025-06-30
Margin bersih-49290.5%2018-06-30 → 2025-06-30
Valuasi & Rasio
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
| Metrik | Tren 5 Tahun | KZIA | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| P/E | -165.9rata-rata 5T ≈-477.0 | ≈-477.0 | · | · |
Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
| Metrik | Tren 5 Tahun | KZIA | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Pretax Margin (Margin Sebelum Pajak) | -53447.6% | · | · | · | |
| Net Profit Margin (Margin Laba Bersih) | -49290.5% | · | · | · | |
| ROA | -149.8%rata-rata 5T ≈-93.8% | ≈-93.8% | · | · | |
| ROE | 226.0%rata-rata 5T ≈-657.6% | ≈-657.6% | · | · |
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
| Metrik | Tren 5 Tahun | KZIA | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Current Ratio (Rasio Lancar) | 0.4rata-rata 5T ≈0.9 | ≈0.9 | · | · | |
| Quick Ratio (Rasio Cepat) | 0.3rata-rata 5T ≈0.8 | ≈0.8 | · | · |
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
Belum ada data untuk grup rasio ini
Data fundamental belum cukup untuk menghitung grup rasio ini.
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
| Metrik | Tren 5 Tahun | KZIA | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Asset Turnover (Perputaran Aset) | 0.0 | · | · | · | |
| Receivables Turnover (Perputaran Piutang) | 0.0 | · | · | · | |
| Revenue / Employee (Pendapatan Tahunan ÷ karyawan (jumlah karyawan, yfinance). Turunan — bukan konsep SEC-XBRL yang tersimpan.) | ≈$7.0K | · | · | · |
nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
-186.5%
| Periode | Laporan | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|---|
| 31 Des. 2025 | $-0.81 | $-0.33 | -142.8% | |
| 30 Juni 2025 | $1.42 | $-1.33 | 207.1% | |
| 31 Des. 2024 | $-12.30 | $-17.44 | 29.5% | |
| 30 Juni 2023 | $-9.50 | $-2.55 | -272.5% | |
| 30 Juni 2022 | $-43.55 | $-5.10 | -753.9% |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $42.0K | $2M | $0 | · | · | · | · | $119.0K | $249.0K | |
| R&D Expense | $7M | $17M | $16M | $20M | $15M | $9M | $6M | $10M | $11M | |
| SG&A Expense | $9M | $14M | $9M | $5M | $7M | $4M | $4M | $6M | $9M | |
| Interest Expense | · | · | · | · | · | · | · | $0 | $1.0K | |
| Interest Income | $72.0K | $12.0K | $22.0K | $2.0K | $42.0K | $66.0K | $100.0K | $119.0K | $249.0K | |
| Pretax Income | $-22M | $-27M | $-21M | $-25M | $-9M | $-13M | $-11M | $-6M | $-11M | |
| Income Tax | $-2M | $-271.0K | $-271.0K | $-368.0K | $-484.0K | $-298.0K | $-298.0K | $-305.0K | $-199.0K | |
| Net Income | $-21M | $-27M | $-20M | $-25M | $-8M | $-12M | $-10M | $-6M | $-11M | |
| EPS (Basic) | $-0.04 | $-0.10 | $-0.11 | $-0.19 | $-0.07 | $-0.17 | $-17.86 | $-12.48 | $-2.28 | |
| EPS (Diluted) | $-0.04 | $-0.10 | $-0.11 | $-0.19 | $-0.07 | $-0.17 | $-17.86 | $-12.48 | $-2.28 | |
| Shares (Basic) | · | · | 184,284,350 | 132,467,686 | 117,674,543 | 73,053,514 | 57,503,555 | 48,376,525 | 467,833,849 | |
| Shares (Diluted) | 547,941,171 | 263,676,313 | 184,284,350 | 132,467,686 | 117,674,543 | 73,053,514 | 57,503,555 | 48,376,525 | 467,833,849 | |
| EBITDA | · | · | · | · | · | $1M | $1M | $2M | · |
Neraca
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4M | $2M | $5M | $7M | $21M | $1M | $834.0K | $3M | $8M | |
| Receivables | $98.0K | $4M | $4M | $91.0K | $84.0K | $1M | $2M | $3M | $4M | |
| Current Assets | $5M | $6M | $11M | $9M | $29M | $11M | $8M | $9M | $19M | |
| PP&E (Net) | · | · | · | · | · | · | · | $1.0K | $490.0K | |
| Intangibles | $1M | $15M | $17M | $19M | $21M | $12M | $13M | $15M | $16M | |
| Total Assets | $6M | $22M | $28M | $36M | $58M | $23M | $21M | $28M | $36M | |
| Accounts Payable | $10M | $15M | $4M | $4M | $5M | $3M | $2M | $2M | $2M | |
| Current Liabilities | $14M | $26M | $8M | $7M | $8M | $5M | $2M | $4M | $5M | |
| Total Liabilities | $14M | $32M | $16M | $18M | $20M | $9M | $7M | $9M | $11M | |
| Retained Earnings | $-135M | $-115M | $-89M | $-69M | $-44M | $-36M | $-25M | $-15M | $-171M | |
| Stockholders' Equity | $-8M | $-10M | $12M | $18M | $38M | $14M | $14M | $19M | $25M |
Arus Kas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | $1M | $1M | $2M | $1M | |
| Other Non-cash | · | · | · | · | · | $3M | $2M | $-4M | · | |
| Operating Cash Flow | $-13M | $-10M | $-15M | $-23M | $-9M | $-9M | $-7M | $-9M | $-11M | |
| CapEx | · | · | · | · | · | · | · | · | $12.0K | |
| Investing Cash Flow | · | $0 | $0 | $-2M | · | · | $2M | $150.0K | $-7M | |
| Financing Cash Flow | $16M | $6M | $13M | $4M | $28M | $12M | $4M | · | $-18.0K |
Profitabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Margin | -49290.5% | · | · | · | · | · | · | -5074.8% | · | |
| Pretax Margin | -53447.6% | · | · | · | · | · | · | -5331.1% | · | |
| EBITDA Margin | · | · | · | · | · | · | · | 1300.0% | · | |
| ROA | -149.8% | -107.8% | -64.0% | -53.5% | -20.8% | -56.4% | -41.6% | -18.9% | · | |
| ROE | 226.0% | -2634.3% | -135.0% | -87.3% | -32.4% | -88.0% | -61.4% | -27.1% | · |
Likuiditas & Solvabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.4 | 0.2 | 1.4 | 1.6 | 3.5 | 2.1 | 4.0 | 2.4 | · | |
| Quick Ratio | 0.3 | 0.2 | 1.2 | 1.6 | 2.5 | 0.5 | 1.3 | 1.4 | · |
Efisiensi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | · | · | · | · | · | 0.0 | · | |
| Receivables Turnover | 0.0 | · | · | · | · | · | · | 0.0 | · |
Per Saham
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $0.00 | · | · | · | · | · | · | $0.00 | · | |
| Cash Flow / Share | $-0.02 | · | $-0.08 | $-0.17 | $-0.08 | $-0.12 | $-0.12 | $-0.18 | · | |
| EPS (TTM) | $-0.04 | $-0.10 | $-0.11 | $-0.19 | $-0.07 | $-0.17 | $-17.86 | $-12.48 | · |
Valuasi (TTM)
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $42.0K | $2M | $0 | · | · | · | · | $119.0K | · | |
| Net Income TTM | $-21M | $-27M | $-20M | $-25M | $-8M | $-12M | $-10M | $-6M | · | |
| P/E | -165.9 | -113.2 | -516.5 | -1112.3 | -6885.5 | -993.0 | -7.3 | -11.9 | · | |
| Earnings Yield | -0.60% | -0.88% | -0.19% | -0.09% | -0.01% | -0.10% | -13.7% | -8.4% | · |
Per Saham
| Metrik | Tren | Q4 2017 | Q4 2016 | Q4 2015 | Q4 2014 | Q4 2013 | Q4 2012 | Q4 2011 | Q4 2010 | Q4 2009 | Q4 2008 | Q4 2007 | Q4 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS (TTM) | $-2.28 | $-2.82 | · | · | · | · | · | · | · | · | · | · |
Valuasi (TTM)
| Metrik | Tren | Q4 2017 | Q4 2016 | Q4 2015 | Q4 2014 | Q4 2013 | Q4 2012 | Q4 2011 | Q4 2010 | Q4 2009 | Q4 2008 | Q4 2007 | Q4 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $249.0K | $406.0K | · | · | · | · | · | · | · | · | · | · | |
| Net Income TTM | $-11M | $-12M | · | · | · | · | · | · | · | · | · | · | |
| P/E | -78.9 | -132.6 | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -1.3% | -0.75% | · | · | · | · | · | · | · | · | · | · |
Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
| Metrik | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-07-01 |
|---|---|---|---|---|---|
| Pendapatan | $42.0K | $2M | $0 | · | · |
| Laba Bersih | $-21M | $-27M | $-20M | $-25M | · |
| EPS Dilusian | $-0.04 | $-0.10 | $-0.11 | $-0.19 | · |
| Metrik | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-07-01 |
|---|---|---|---|---|---|
| Rasio Lancar | 0.4 | 0.2 | 1.4 | 1.6 | · |
| Rasio Cepat | 0.3 | 0.2 | 1.2 | 1.6 | · |
Tidak ada data untuk laporan ini
Data fundamental belum cukup untuk membuat laporan ini.
Pemilik institusional (13F) 40 pengaju · $56.3M total · Per tanggal 30 Juni 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Pemegang
40
Nilai yang dipegang
$56.3M
Posisi baru
22
Posisi yang keluar
5
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 22 (+15 vs Kuartal sebelumnya) | 5 (-1 vs Kuartal sebelumnya) | 10 (+3 vs Kuartal sebelumnya) | 4 (0 vs Kuartal sebelumnya) | +2.3M |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| Boxer Capital Management, LLC | $7.884.800 | 560.000 | 14,01% | Saham |
| FLPUTNAM INVESTMENT MANAGEMENT CO | $5.842.609 | 414.958 | 10,38% | Saham |
| Bleichroeder LP | $5.632.000 | 400.000 | 10,00% | Saham |
| Ikarian Capital, LLC | $5.578.510 | 396.201 | 9,91% | Saham |
| Dauntless Investment Group, LLC | $4.987.249 | 354.208 | 8,86% | Saham |
| Stonepine Capital Management, LLC | $4.860.120 | 345.179 | 8,63% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $3.543.936 | 251.700 | 6,29% | Opsi beli |
| Point72 Asset Management, L.P. | $2.304.224 | 200.300 | 4,09% | Saham |
| Ensign Peak Advisors, Inc | $1.559.754 | 110.778 | 2,77% | Saham |
| MILLENNIUM MANAGEMENT LLC | $1.427.374 | 101.376 | 2,54% | Saham |
| UBS Group AG | $1.141.748 | 81.090 | 2,03% | Saham |
| CITADEL ADVISORS LLC | $1.070.080 | 76.000 | 1,90% | Opsi beli |
| J. Goldman & Co LP | $964.353 | 68.491 | 1,71% | Saham |
| ADAR1 Capital Management, LLC | $866.624 | 61.550 | 1,54% | Saham |
| JANE STREET GROUP, LLC | $804.531 | 57.140 | 1,43% | Saham |
| BARCLAYS PLC | $802.546 | 56.999 | 1,43% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $712.673 | 50.616 | 1,27% | Saham |
| COOPERMAN LEON G | $704.000 | 50.000 | 1,25% | Saham |
| Westside Investment Management, Inc. | $669.997 | 47.585 | 1,19% | Saham |
| MORGAN STANLEY | $656.212 | 46.606 | 1,17% | Saham |
| MARSHALL WACE, LLP | $622.772 | 44.231 | 1,11% | Saham |
| JANE STREET GROUP, LLC | $506.880 | 36.000 | 0,90% | Opsi beli |
| XTX Topco Ltd | $439.099 | 31.186 | 0,78% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $430.848 | 30.600 | 0,77% | Opsi jual |
| BNP PARIBAS FINANCIAL MARKETS | $423.667 | 30.090 | 0,75% | Saham |
| CITADEL ADVISORS LLC | $401.407 | 28.509 | 0,71% | Saham |
| RAYMOND JAMES FINANCIAL INC | $318.194 | 22.599 | 0,57% | Saham |
| Sequoia Financial Advisors, LLC | $281.643 | 20.003 | 0,50% | Saham |
| Engineers Gate Manager LP | $210.848 | 14.975 | 0,37% | Saham |
| Laird Norton Wetherby Trust Company, LLC | $181.632 | 12.900 | 0,32% | Saham |
| UNITED BANK | $180.941 | 12.851 | 0,32% | Saham |
| Rockefeller Capital Management L.P. | $178.816 | 12.700 | 0,32% | Saham |
| JPMORGAN CHASE & CO | $41.399 | 2.863 | 0,07% | Saham |
| GAMMA Investing LLC | $27.118 | 1.926 | 0,05% | Saham |
| RAYMOND JAMES FINANCIAL INC | $20.000 | 2.000 | 0,04% | Opsi beli |
| RHUMBLINE ADVISERS | $18.245 | 1.296 | 0,03% | Saham |
| Arax Advisory Partners | $1.225 | 87 | 0,00% | Saham |
| Caitong International Asset Management Co., Ltd | $338 | 24 | 0,00% | Saham |
| OSAIC HOLDINGS, INC. | $140 | 10 | 0,00% | Saham |
| Allworth Financial LP | $15 | 1 | 0,00% | Saham |
Aktivis & pemilik 5%+ 4 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| SS. OR ×13 pengajuan | 25 Nov. 2013 | · | Pengajuan awal | · | SEC |
| Novogen Limited (2) ×6 pengajuan | 7 Des. 2012 | · | Pengajuan awal | M&A / penjualan | SEC |
| Novogen Limited ×2 pengajuan | 11 Mei 2011 | · | Pengajuan awal | M&A / penjualan | SEC |
| Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan | 4 April 2006 | · | Pengajuan awal | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Orang dalam perusahaan 8 orang dalam · 5 pejabat · 3 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| John E. Friend II | Chief Executive Officer | 8 Jan. 2026 A | · | 0 | 0 | $0 |
| James E. Levine | Chief Financial Officer | 19 Juni 2026 A | · | 0 | 0 | $0 |
| Sudha Rao | Chief Scientific Officer | 19 Juni 2026 A | · | 0 | 0 | $0 |
| David Cain | Director, CMC | 8 Jan. 2026 A | · | 0 | 0 | $0 |
| Jeffrey Bonacorda | VP, Finance and Controller | 8 Jan. 2026 A | · | 0 | 0 | $0 |
| Ebru Davidson | Direktur | 8 Jan. 2026 A | · | 0 | 0 | $0 |
| Steven R. S. Coffey | Direktur | 8 Jan. 2026 A | · | 0 | 0 | $0 |
| Robert F Apple | Direktur | 8 Jan. 2026 A | · | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
KZIA Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
peringkat · 12 analis
BELI
Target median
$29.00
+212,8%
3 25,0%
Beli Kuat
8 66,7%
Beli
1 8,3%
Tahan
0 0,0%
Jual
0 0,0%
Jual Kuat
Target Harga 12 Bulan
6 analis · 2026-10-03Target rata-rata $28.25 +204,7%
← Di bawah semua target
Harga saat ini $9.27
Rendah$17.43
Rata-rata$28.25
Tinggi$39.07
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Sumber: SEC 20-F diajukan Nov 7, 2025